Patents by Inventor Dalia Rotman

Dalia Rotman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral aerosol compositions and pressurized containers containing same
    Patent number: 5049589
    Abstract: The invention relates to antiviral compositions of matter containing as active ingredient hypericin or pseudohypericin. The novel compositions are of special use in the treatment of, and alleviation of symptons of various diseases caused by viruses such as vesicular stomatitis, influenza, herpes simplex, HSV-1 and HSV-2. The mode of activity seems to be by inhibition of RNA synthesis and interfering with virus replication. The pharmaceutical compositions can be applied by a variety of routes. Topical applications have proved to be effective against a variety of viral afflictions.
    Type: Grant
    Filed: December 19, 1989
    Date of Patent: September 17, 1991
    Assignee: Yeda Research and Development Company, Ltd.
    Inventors: David Lavie, Michel Revel, Dalia Rotman, Vincent Vande Velde
  • Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
    Patent number: 5047435
    Abstract: Pharmaceutical formulations comprising aromatic polycyclic dione compounds useful for treating mammals suffering from diseases caused by retroviruses are disclosed herein. A method for treating mammals suffering from retrovirus infections is also disclosed.
    Type: Grant
    Filed: March 27, 1989
    Date of Patent: September 10, 1991
    Assignees: New York University, Yeda Research and Development Company, Ltd.
    Inventors: David Lavie, Daniel Meruelo, Gad Lavie, Michel Revel, Vincent Vande Velde, Dalia Rotman
  • Antiviral compositions
    Patent number: 4898891
    Abstract: The invention relates to antiviral compositions of matter containing as active ingredient hypericin or pseudohypericin. The novel compositions are of special use in the treatment of, and alleviation of symptoms of various diseases caused by viruses such as vesicular stomatitis, influenza, herpes simplex, HSV-1 and HSV-2. The mode of activity seems to be by inhibition of RNA synthesis and interfering with virus replication. The pharmaceutical compositions can be applied by a variety of routes. Topical applications have proved to be effective against a variety of viral afflictions.
    Type: Grant
    Filed: August 7, 1987
    Date of Patent: February 6, 1990
    Assignee: Yeda Research and Development Company Ltd.
    Inventors: David Lavie, Michel Revel, Dalia Rotman, Vincent V. Velde